Cargando…
Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's Disease
Previous studies have reported elevated levels of biogenic aldehydes in the brains of patients with Parkinson's disease (PD). In the brain, aldehydes are primarily detoxified by aldehyde dehydrogenases (ALDH). Reduced ALDH1 expression in surviving midbrain dopamine neurons has been reported in...
Autores principales: | Wey, Margaret Chia-Ying, Fernandez, Elizabeth, Martinez, Paul Anthony, Sullivan, Patricia, Goldstein, David S., Strong, Randy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284575/ https://www.ncbi.nlm.nih.gov/pubmed/22384032 http://dx.doi.org/10.1371/journal.pone.0031522 |
Ejemplares similares
-
Bioactivation of Nitroglycerin by Purified Mitochondrial and Cytosolic Aldehyde Dehydrogenases
por: Beretta, Matteo, et al.
Publicado: (2008) -
Benomyl, Aldehyde Dehydrogenase, DOPAL, and the Catecholaldehyde
Hypothesis for the Pathogenesis of Parkinson’s Disease
por: Casida, John E., et al.
Publicado: (2014) -
Identification of a novel cytosolic aldehyde dehydrogenase allele, ALDHIAI*4
por: Moore, Shelley M, et al.
Publicado: (2009) -
Neurochemical and motor changes in mice with combined mutations linked to Parkinson’s disease
por: Bai, Xiang, et al.
Publicado: (2017) -
Mitochondrial aldehyde dehydrogenase and cardiac diseases
por: Chen, Che-Hong, et al.
Publicado: (2010)